Role of Cerebral Oximetry in Reducing Postoperative Morbidity Following Cardiac Surgery
- Conditions
- Postoperative Complications
- Interventions
- Other: Correction rSO2 desaturation.Other: Standard treatment
- Registration Number
- NCT02155868
- Lead Sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Brief Summary
Cerebral oximetry employing near-infrared spectroscopy (NIRS) is a non-invasive modality used to estimate regional cerebral oxygen content saturation (rSO2). Near-infrared spectroscopy has increasingly been used in perioperative setting of heart surgery and many studies have outlined an increased incidence of postoperative morbidity in patients with significant perioperative reductions in rSO2. Although a relationship between rSO2 reductions and adverse outcomes has been reported, there is not compelling evidence that interventions to correct rSO2 during cardiac surgery lead to improved clinical outcomes.
Hypothesis of the study is that interventions to normalize intraoperatively decreased cerebral rSO2 would reduce the overall incidence of postoperative complications in high-risk cardiac surgery patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
High-risk cardiac surgery patients as determined by at least one of the followings:
- the age greater than or equal to 75 years on the day of screening;
- left ventricle ejection fraction less than 35%;
- use of a preoperative intraaortic balloon pump;
- combined valve and coronary artery surgery or multiple valve surgery in patients who have congestive heart failure, or renal insufficiency (creatinine clearance < 60 ml/min)
- refusal of consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Correction rSO2 desaturation. Cerebral NIRS monitoring by means of FORE-SIGHT Universal Cerebral Oximeter MC-2030C. Predefined protocol of interventions for correcting rSO2 desaturation (\< 60%) during cardiac surgery and the first six hours after it. Control Standard treatment Only cerebral NIRS monitoring by means of FORE-SIGHT Universal Cerebral Oximeter MC-2030C during cardiac surgery and the first six hours after it.
- Primary Outcome Measures
Name Time Method Incidence of postoperative complications Up to 30 day after randomisation This composite outcome includes: myocardial infarction, stroke, delirium, postoperative cognitive dysfunction, wound infection, mediastinitis, mechanical ventilation more than 24 h, arrhythmia, reoperation for bleeding, acute kidney injury, and acute kidney injury requiring dialysis.
- Secondary Outcome Measures
Name Time Method Duration of postoperative hospital stay Up to 30 day after randomization Incidence of major organ morbidity and mortality Up to 30 day after randomization This outcome includes: stroke, acute kidney injury requiring dialysis, mechanical ventilation more than 48 h, mediastinitis, reoperation, and death
Death from all causes at 30 days Up to 30 day after randomisation Duration of intensive care unit stay Up to 30 day after randomization
Trial Locations
- Locations (1)
Academician EN Meshalkin Novosibirsk State Budget Research Institute of Circulation Pathology
🇷🇺Novosibirsk, Novosibirsk Territory, Russian Federation